Global /South Korea /Healthcare /Drug Manufacturers - Specialty & Generic /002390
chevron_leftBack
HANDOK Inc. logo

HANDOK Inc.

002390
KRX: 002390 Delayed
10,310KRW -1.8%
6.83 USD
As of 18 June 2026, HANDOK Inc. has a market cap of $89.43M USD, ranking #26309 globally and #1308 in South Korea. It ranks #2358 in the Healthcare sector, and #126 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
26309
Country Rank
1308
Sector Rank
2358
Industry Rank
126
Key Stats
Market Cap
$89.43MUSD
136.41B KRW
Enterprise Value
$323.72MUSD
488.63B KRW
Revenue (TTM)
$350.84MUSD
535.14B KRW
EBITDA (TTM)
$17.76MUSD
26.8B KRW
Net Income (TTM)
-$1.41MUSD
-2.15B KRW
EBITDA Margin
5%
Profit Margin
-0.4%
PS Ratio
0.3
PB Ratio
0.5
EV/EBITDA
30.4
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Young-Jin Kim open_in_new
Employees
940
Founded
1954
Website
handok.co.kr open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-1.8% 0.6% -2.3% -7.8% -9.2% -11%

News

Loading...

Markets

Exchange Ticker Price
Korea Exchange
MIC: XKRX
PRIMARY
002390
(주)한독
ISIN: KR7002390003
Shares Out.:
12.991M1 Shares Float: 7.514M2
TV:
SA:
YF:
GF:
BA:
MS:
10,310 KRW
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About HANDOK Inc.

HANDOK Inc. operates as a pharmaceutical company. The company provides prescription and OTC drugs; medical devices, such as blood pressure monitors, cholesterol monitoring systems, insulin pumps, self-monitoring system of blood glucose, and blood glucose monitoring system; in vitro diagnostic medical devices; as well as life science products. It also offers healthcare products comprising food supplements under the NatureSet brand; food and beverages; and medical nutrition products. In addition, the company engages in real estate leasing. The company was formerly known as Handok Pharmaceuticals Co., Ltd and changed its name to Handok Inc. in July 2013. Handok Inc. was founded in 1954 and is headquartered in Seoul, South Korea.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (South Korea)
Name
Market Cap diff.
PE
$541.76M
826.36B KRW
506%
8.4
220100
$279.45M
426.25B KRW
212%
-
200130
$219.63M
335.01B KRW
146%
-
$204.29M
311.61B KRW
128%
16.3
194700
$168.04M
256.31B KRW
88%
7.4
$99.27M
151.41B KRW
11%
17.8
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
PE
$37.36B
108.92B ILS
42K%
24.2
$29.56B
33K%
-
$15.88B
107.34B CNY
18K%
16.0
CIPLA
$11.26B
1.06T INR
12K%
23.4
LUPIN
$11.15B
1.05T INR
12K%
22.7
$9.11B
61.6B CNY
10K%
80.6
chevron_leftBack